Everest Medicines to Attend the 44th Annual JPMorgan Healthcare Conference and Deliver a Keynote Speech

Shanghai, China — January 6, 2026 — Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on innovative drug research and development, clinical development, manufacturing, and commercialization, announced today that Mr. He Ying, President and Chief Financial Officer, will attend the 44th JPMorgan Annual Healthcare Conference and provide an update on the company’s recent developments. As the most influential investment and collaboration event in the global healthcare field, this year's conference will be held from January 12 to 15, 2026, in San Francisco, USA. The core management team of Everest Medicines, including Chairman of the Board Wu Yifang and Chief Executive Officer Luo Yongqing, will also attend the investor meetings.

Time: 7:30 AM Pacific Standard Time, January 15, 2026 (11:30 PM Beijing Time, January 15, 2026)

Time: January 12-15, 2026

Everest Medicines’ management will arrange investor meetings during the JPMorgan Healthcare Conference. Interested parties can schedule appointments via the JPMorgan system or by sending an email to access@lifesciadvisors.com.

The information contained in this press release may include certain forward-looking statements based on the Company or management’s current views, beliefs, and expectations regarding the Company’s business operations and financial conditions at the time of making the statements. Such forward-looking statements may use words like 'will,' 'expect,' 'forecast,' 'anticipate,' 'intend,' 'plan,' 'believe,' 'estimate,' 'confident,' and similar terms. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond the Company’s control and difficult to predict. Therefore, actual results may differ materially from those implied by the forward-looking statements due to various factors and assumptions, including changes and developments in the Company’s business, competitive environment, political, economic, legal, and social circumstances. Neither the Company nor its subsidiaries, directors, officers, advisors, or agents assume any obligation to update the forward-looking statements contained in this press release to reflect subsequent information, events, or circumstances after the date of this release, unless required by law.